Trades on 1 secondary market
Ankyra Therapeutics
Ankyra Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, developing "anchored" immunotherapies for cancer and immune-mediated diseases. Its proprietary platform tethers immune-modulating drugs to aluminum hydroxide so that treatment concentrates locally at the
Ankyra Therapeutics is an API provider whose private shares are listed on 1 secondary market: Forge Global.
Where It Trades
Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.